fbpx Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science.

Partnerships Form to Boost Coronavirus Vaccine Production, Pfizer’s Deal with Valneva, Remdesivir Shows Modest Benefits in Trial

  • 2020-04-30T19:00:00.000+0000
  • California
  • Author: Lauren Panetta

4/30/20 – FiercePharma

Vertex, even amid pandemic, raises sales projections thanks to gangbusters start for Trikafta

4/30/20 – BioPharma Dive

J&J contracts with Catalent to boost coronavirus vaccine production

4/30/20 – Endpoints

Amid Covid-19 hunt, Pfizer adds Lyme disease vaccine in $308M deal with Valneva

4/30/20 – CalciMedica

CalciMedica Expands Clinical Study to Assess CM4620-IE in Patients with Critical COVID-19 Pneumonia on High-Flow Oxygen Therapy

4/29/20 – FiercePharma

GSK partners with Arthritis Foundation as it preps Voltaren for OTC switch

4/29/20 – Endpoints

Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure

4/29/20 – GenomeWeb

UCSF, Stanford, CZ Biohub Receive $13.6M to Study Bay Area COVID-19 Spread

4/29/20 – San Francisco Business Times

Alexandria completes planned acquisitions for San Carlos biotech campus

4/29/20 – The New York Times

Remdesivir Shows Modest Benefits in Coronavirus Trial

4/29/20 – UC San Diego

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

4/28/20 – Endpoints

Covid-19 roundup: Researchers claim trial success for Roche's Actemra as Alexion jumps in; Pfizer gambling $500M on an ambitious campaign

4/28/20 – Endpoints

Astellas partners with Insilico, Harvard; Zambon gets FDA's fast track status for lung drug

4/27/20 – Xconomy

Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic

4/27/20 – Xconomy

Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill

4/24/20 – Xconomy

ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies

4/24/20 – Endpoints

Eli Lilly execs have been thinking about the longterm effects of the pandemic and damage control. Here’s what they believe

4/23/20 – Xconomy

Nitrome Bio Bags $38M to Prep Parkinson’s Program for the Clinic

4/22/20 – BioPharma Dive

Coronavirus vaccine from BioNTech, Pfizer set to enter testing in Germany

4/22/20 – BioSpace

Biogen’s Expected Filing for Alzheimer’s Drug Aducanumab Delayed Until Q3

4/20/20 – BioPharma Dive

Positive data keep Bristol Myers and Exelixis in the kidney cancer race